Sign inJoin waitlistJoin the waitlist

Bradley DeNardo

Director · Rhode Island Hospital/Brown University Health

Credentials: · ·

History

Rhode Island Hospital/Brown University Health
Present

Pediatric Hematology/Oncology
Rhode Island Hospital/Brown University Health
2011–2014
Pediatrics
Rhode Island Hospital/Brown University Health
2008–2011
Warren Alpert Medical School of Brown University
2004–2008

Research

Quantitative phosphoproteomic analysis identifies activation of the RET and IGF-1R/IR signaling pathways in neuroblastoma
PLoS ONE · 2013 · First of 8 authors · 28 citations
Durable changes in the gut microbiome in survivors of childhood acute lymphoblastic leukemia
Pediatric Blood & Cancer · 2021 · 8 citations
An asymptomatic mutation complicating severe chemotherapy-induced peripheral neuropathy (CIPN): a case for personalised medicine and a zebrafish model of CIPN
npj Genomic Medicine · 2016 · 8 citations

Jennifer Welch
4 papers
Roma Bhuta
3 papers · 2 as a fellow
Brian Crompton
2 papers
CP
Chanika Phornphutkul
2 papers
David Shulman
2 papers
Don Dizon
2 papers
Jan Groblewski
2 papers
Jason Shapiro
2 papers
RA
Rachel Altura
2 papers
Steven DuBois
2 papers
AK
Abhijeet Kumar
1 paper
AK
Adam Kronish
1 paper · 1 as a resident

Clinical trials

Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
Principal investigator · Withdrawn · Phase 2
Brown University
2022–2030
A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas
Principal investigator · Withdrawn · Phase 2
Brown University
2021–2025
Quality of End-of-Life Care for Children With Cancer
Site PI · Recruiting
Children's Oncology Group
2026–2031
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2026–2031